实时心脏团队在复杂冠心病血运重建中的随机对照试验
EHEART 随机对照试验在 3 个心脏中心纳入 490 例左主干或三支病变患者,比较造影期间在线会议实时心脏团队与常规面对面心脏团队决策。实时组治疗等待时间、再导管率、专家高负荷率及 PCI 住院费用均降低,1 年 MACCE 非劣于常规组,但多学科同步共享决策比例较低。
要点
- 实时心脏团队可缩短治疗等待时间并提高诊疗效率,且 1 年 MACCE 非劣于常规心脏团队。
- 实时组再导管率和专家高负荷率显著降低,PCI 住院费用下降。
- 实时组多学科同步共享决策比例低于常规组,推广前需优化。
核心结论
- 在复杂冠心病患者中,实时心脏团队较常规心脏团队显著改善诊疗效率和过程评价指标,临床结局与血运重建决策相似。
研究设计与样本
- 非劣效随机对照试验,在 3 个心脏中心纳入 490 例新发左主干或三支病变患者,每组 245 例。
主要发现
- 最终治疗等待时间中位数实时组 2 天(Q1-Q3:0-7 天) vs 常规组 5 天(Q1-Q3:2-10 天),P < 0.001。
- 再导管率实时组 12.5% vs 常规组 98.9%,P < 0.001。
- 专家高负荷率实时组 5.3% vs 常规组 29.0%,P < 0.001。
- PCI 住院费用实时组下降 18.0%,P < 0.001。
- 1 年 MACCE 实时组 8.2% vs 常规组 10.6%,风险差 -2.45%(95% CI:-7.61%-2.71%),非劣效 P < 0.001。
临床怎么用
- 对于复杂冠心病血运重建决策,可考虑采用造影期间在线会议的实时心脏团队模式以提高效率。
- 实施实时心脏团队时需关注共享决策不足的问题,并评估跨中心推广的可行性。
局限性
- 实时心脏团队模式下多学科同步共享决策比例较低(2.0% vs 11.5%)。
- 研究仅纳入 3 个心脏中心,跨中心推广性需进一步优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The routine implementation of heart teams for patients with complex coronary artery disease (CAD) is challenging due to the insufficient multidisciplinary specialist resources for face-to-face discussion. A real-time heart team during the angiography, based on an online meeting, offers the potential to efficiently integrate resources. OBJECTIVES: In this study, we sought to evaluate the implementation value and safety of a "real-time heart team" decision making approach. METHODS: This noninferiority randomized controlled trial enrolled patients with de novo left main or 3-vessel CAD at 3 cardiac centers. Patients were randomly assigned to the conventional heart team group (discussed by a face-to-face meeting after the angiography) or the real-time heart team group (discussed by an online meeting during the angiography). Implementation value outcomes included care efficiency (waiting time for treatment, recatheterization, specialist workload, and economic outcomes) and process evaluation metrics (discussion adequacy, surgeon participation, and shared decision making). The safety outcomes were a composite of 1-year major adverse cardiovascular and cerebrovascular events (MACCE) (including all-cause mortality, myocardial infarction, stroke, unplanned revascularization, and readmission due to reangina) and revascularization decision making. RESULTS: Overall, 490 complex CAD patients were included, with 245 patients in each group. Waiting time for final therapy (median: 2 days [Q1-Q3: 0-7 days] vs 5 days [Q1-Q3: 2-10 days]; P < 0.001), recatheterization rate (12.5% vs 98.9%; P < 0.001), specialist high workload rate (5.3% vs 29.0%; P < 0.001), and percutaneous coronary intervention (PCI) hospitalization cost (percentage of decrease: 18.0%; P < 0.001) were significantly reduced in the real-time group. More discussion time spent (4.0 ± 1.8 min vs 3.4 ± 1.6 min), better specialist satisfaction (based on NASA Task Load Index scale), more chief surgeon participation (26.5% vs 18.8%), but less multidisciplinary synchronous shared decision making (2.0% vs 11.5%) were found in the real-time group. The real-time heart team group was noninferior to the conventional group in 1-year MACCE (8.2% vs 10.6%; risk difference: -2.45%; 95% CI: -7.61%-2.71%; P for noninferiority < 0.001). The proportions of PCI, coronary artery bypass grafting, and medical therapy were similar between the 2 groups (P = 0.892). CONCLUSIONS: Compared with the conventional heart team, the real-time heart team significantly improved care efficiency and process evaluation metrics, with similar clinical outcomes and decision making. However, insufficient shared decision making and intercenter generalizability should be optimized before widespread implementation of this approach. (Feasibility and Effectiveness of a Real-Time Heart Team Approach in Complex CAD [EHEART; NCT05514210]).
引用
- Lin S, Su X, Ma H, et al. Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease: The EHEART Randomized Trial. J Am Coll Cardiol. 2026. PMID: 41778947. doi:10.1016/j.jacc.2026.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。